Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Burkhard Jandrig"'
Autor:
Raik Schneider, Günther Gademann, Hans-Joachim Ochel, Karsten Neumann, Burkhard Jandrig, Peter Hass, Mathias Walke, Martin Schostak, Thomas Brunner, Frank Christoph
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Epidermal Growth Factor Receptor is often overexpressed in advanced prostate carcinoma. In-vitro-studies in prostate carcinoma cell line DU145 have demonstrated increased sensibility to radiation after cetuximab treatment, but cli
Externí odkaz:
https://doaj.org/article/6ec71033d66d40c4ae7284bdf61dce0a
Autor:
Dennis Gürgen, Michael Becker, Mathias Dahlmann, Susanne Flechsig, Elke Schaeffeler, Florian A. Büttner, Christian Schmees, Regina Bohnert, Jens Bedke, Matthias Schwab, Johann J. Wendler, Martin Schostak, Burkhard Jandrig, Wolfgang Walther, Jens Hoffmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient’s life. Patients with advanced, metastasized RCC have a poor prognosis. The majority of patients develop treatment resistance towar
Externí odkaz:
https://doaj.org/article/7ac4640177bd4ea9bb1cc13c5cadf092
Autor:
Christopher Hampf, Martin Bialke, Lars Geidel, Albert Vass, Thomas Bahls, Romina Blasini, Arne Blumentritt, Martin Boeker, Christian Bruns, Burkhard Jandrig, Maximilian Fünfgeld, Philipp Heinrich, Torsten Leddig, Achim Michel-Backofen, Anna Pirkl, Michael Rautenberg, Fabian Simons, Dana Stahl, Hans-Ulrich Prokosch, Wolfgang Hoffmann
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Background The consent management is an essential component for supporting the implementation of consents and withdrawals and thus, the realisation of patient’s rights. In MIRACUM, one of the four consortia of the Medical Informatics Initi
Externí odkaz:
https://doaj.org/article/451d6adee9444b09882a43b2a2c44a0f
Autor:
JETON LUZHA, NORBERT NASS, PIOTR CZAPIEWSKI, NICOLAS SCHROEDER, THOMAS KALINSKI, MARTIN SCHOSTAK, CHRISTOPH SCHATZ, BURKHARD JANDRIG, JOHANNES HAYBAECK
Publikováno v:
Anticancer Research. 43:1437-1448
Autor:
Burkhard Jandrig, Hans Krause, Wolfgang Zimmermann, Emilija Vasiliunaite, Alma Gedvilaite, Rainer G. Ulrich
Publikováno v:
Viruses, Vol 13, Iss 5, p 907 (2021)
Hamster polyomavirus (Mesocricetus auratus polyomavirus 1, HaPyV) was discovered as one of the first rodent polyomaviruses at the end of the 1960s in a colony of Syrian hamsters (Mesocricetus auratus) affected by skin tumors. Natural HaPyV infections
Externí odkaz:
https://doaj.org/article/1319f91824694ee0a7b423eee0b92c18
Autor:
Dennis Kobelt, Dennis Gürgen, Michael Becker, Mathias Dahlmann, Susanne Flechsig, Elke Schaeffeler, Florian A. Büttner, Christian Schmees, Regina Bohnert, Jens Bedke, Matthias Schwab, Johann J. Wendler, Martin Schostak, Burkhard Jandrig, Wolfgang Walther, Jens Hoffmann
Publikováno v:
Cancer Research. 83:44-44
Renal cell carcinoma (RCC), is the most common kidney cancer of adults, originating in the lining of the proximal convoluted tubule. Prognosis is poor in patients with advanced or metastasized RCC. Drug resistance towards Standard of Care (SoC, incl.
Autor:
Maria Friedrich, Johann Jakob Wendler, Daniel Baumunk, Martin Schostak, Burkhard Jandrig, Jorn H Witt, Markus Porsch, Uwe-B. Liehr
Publikováno v:
BJU internationalReferences. 130(4)
OBJECTIVE To assess the potential for molecular staging in biopsies of the prostatic fossa after radical prostatectomy (RP) by searching for occult tumour cells through analysis of glutathione S-transferase P1 (GSTP1) methylation status. PATIENTS AND
Autor:
Peter Hass, Karsten Neumann, Thomas Brunner, Martin Schostak, Mathias Walke, Hans-Joachim Ochel, Günther Gademann, Raik Schneider, Burkhard Jandrig, Frank Christoph
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Epidermal Growth Factor Receptor is often overexpressed in advanced prostate carcinoma. In-vitro-studies in prostate carcinoma cell line DU145 have demonstrated increased sensibility to radiation after cetuximab treatment, but clinical dat
Autor:
Martin Bialke, Martin Boeker, Michael Rautenberg, Romina Blasini, Achim Michel-Backofen, Arne Blumentritt, Lars Geidel, Albert Vass, Torsten Leddig, Fabian Simons, Dana Stahl, Burkhard Jandrig, Maximilian Fünfgeld, Christopher Hampf, Wolfgang Hoffmann, Philipp Heinrich, Thomas Bahls, Hans-Ulrich Prokosch, Anna Pirkl, Christian Bruns
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Background The consent management is an essential component for supporting the implementation of consents and withdrawals and thus, the realisation of patient’s rights. In MIRACUM, one of the four consortia of the Medical Informatics Initiative (MI
Autor:
Johannes Müller, Martin Schostak, Peter Göttel, Johann Jakob Wendler, Niels-Peter Becker, Burkhard Jandrig, Ingolf Schimke, Gerd Wallukat
Publikováno v:
Autoimmunity Highlights
Background For prostate cancer, signaling pathways induced by over-boarding stimulation of G-protein coupled receptors (GPCR) such as the endothelin, α1- and β-adrenergic, muscarinic and angiotensin 1 receptors were accused to support the carcinoge